Journal of Clinical Psychopharmacology

Article	Citations
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia	42
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition	39
Author Index 2022	28
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report	28
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms	26
Postinjection Syndrome After Paliperidone?	25
Dysphagia to Liquids Only Associated With Olanzapine	23
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient	22
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates	21
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?	18
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting	17
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration	16
Question	16
The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience	16
Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation	16
Trazodone and Mianserin for Delirium	16
Risperidone-Induced Priapism	15
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients	15
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman	15
Impact of Adjuvant GLP-1RA Treatment on the Adherence of Second-Generation Antipsychotics in Nondiabetic Adults	15
Possibly Misleading Pharmaceutical Advertising On TV	14
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease	14
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment	14
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings	13
Thoughts on the Value of Case Series in the Literature	13

Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux	12
Zopiclone Discontinuation–Associated Transient Sleepwalking Behavior	12
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus	12
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use	12
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?	12
The Cardiac Cost of Lithium	12
Drug-Associated Liver Injury Related to Antipsychotics	11
Escitalopram-Associated Drug Rash	11
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia	11
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice	11
Pharmacological Treatment and Cognition in Bipolar I Disorder	11
Drug Interaction Between Clozapine and Rifampicin	11
Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers	10
Restless Legs Syndrome Associated With Brexpiprazole	10
Treatment of Acute Intermittent Porphyria–Associated Anxiety Disorder With Gabapentin	10
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum	9
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders	9
SALUTE TO OUR REVIEWERS	9
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio	9
Betamethasone-Associated Psychosis in a Pregnant Woman Diagnosed With Schizophrenia	9
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders	9
Clozapine for Severe Irritability in Children and Adolescents With Autism Spectrum Disorder	9
Neuroleptic Malignant Syndrome Associated With Lurasidone	9
Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy	9
Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine	8
Journal of Clinical Psychopharmacology Updates	8
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine	8
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104	8
Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine	8
A Case of Akathisia After Administration of a Very Low Dose of Mirtazapine	8
Question	8
Letter to the Editors in Response to: Flanagan RJ, Hunter S, Obee S, Reeves S. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	8
Fluvoxamine Augmentation of Clozapine and Dose-dependent Interaction Patterns	8
Use of Risperidone Long-Acting Injection in the Treatment of Anorexia Nervosa: A Case Report	8
Improvement of Compulsive Shopping on Tirzepatide	7
Higher Neutrophil-to-Lymphocyte Ratio Is Associated With Better Response to Esketamine in Treatment-Resistant Depression	7
Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum Disorder Comorbid With Schizophrenia	7
Use of Clozapine in Pregnancy	7
Safety of Intranasal Esketamine Administration in Brugada Syndrome	7
The Clinical and Economic Burden of Tardive Dyskinesia in Israel	7
CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone	7
Incorporating Real-World Treatment Data Into Clozapine's Product Label	7
Long-Term Course of Illness With Rapid-Cycling Bipolar Disorder	7
Question	7
Plasma Clozapine in Treatment Refractory Schizophrenia	7
Haloperidol-Induced Brugada-Pattern Electrocardiogram—A Case Report and a Review of the Literature	6
Mania Associated With Cariprazine	6
Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature	6
Clozapine- and Lithium-Associated Myoclonus	6
Mania-Like Reaction Secondary to Sodium Oxybate	6

Alpha Lipoic Acid for Schizophrenia	6
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient	6
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer	6
A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials	6
Limitations in Recent Study of Clozapine Use During Pregnancy	6
Resolution of Catatonia With Cariprazine—A Case Report	6
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist	6
Clozapine-Associated Agranulocytosis	5
Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants	5
Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?	5
Valproic Acid–Associated Hyperammonemia	5
Malignant Catatonia and Neuroleptic Malignant Syndrome Overlap in the Emergency Department	5
Pharmacokinetics of Ketamine Transfer Into Human Milk	5
Clozapine Use in Down Syndrome	5
Piracetam for Risperidone-associated Hypersalivation	5
Clozapine Associated Periorbital Edema in First Episode Psychosis	5
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders	5
Author Index 2024	5
Therapeutic Interventions and Clinical Outcomes Following Breakthrough Psychosis on Antipsychotic Maintenance Medication (BAMM)	5
Therapeutic Drug Monitoring of Paliperidone in Patients With Schizophrenia in Taiwan	5
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder	5
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD	5
Subject Index 2022	5
Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient	5
Esketamine for Unipolar Major Depression With Psychotic Features	4
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders	4
Exploring the Addictive Potential of Tranylcypromine	4
Hematological and Other Cancers in People Using Clozapine	4
Clozapine-associated Retrograde Ejaculation	4
Neurotoxicity Related to Multidrug Association: A Case Report	4
Methylphenidate-Associated Syncope	4
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression	4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia	4
The Need for Non-profit Psychiatric Drug Discovery and Development	4
Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients	4
Reversible Valproic Acid–Associated Cerebral Pseudoatrophy in a 53-Year-Old Male With Bipolar I Disorder	4
Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors	4
The Association Between Mood Stabilizers, Sleep Quality, and Functioning in Patients With Remitted Bipolar Disorder	4
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use	4
Detecting Anxious Distress, an Important Mood Specifier	4
Characterization of Extended-Release Lorazepam	4
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning	4
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report	4
Improving Result Turnaround Time as a Crucial Factor to Increasing Clozapine Therapeutic Drug Monitoring in Hospitalized Patients	4
Myoclonic Movements and Catatonic-Like Symptoms After Abrupt Cessation of Clozapine	4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation	4
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)	4
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series	4
Question	4
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder	4
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination	4
Response to Letter to the Editors From Prof D. Taylor	4
You Shall Not Turn a Blind Eye to Intraocular Pressure	4
Article Selected to Receive the Mitchell B. Balter Award for 2022	4
Clonidine and Trihexyphenidyl in Clozapine-induced Hypersalivation	4
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset	4
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine	3
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants	3
Toward Precision Psychiatry	3
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia	3
Tardive Dyskinesia Suppressed With Ginkgo Biloba	3
Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders	3
Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease	3
The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine	3
Critical Lithium Level in a Nontoxic Outpatient	3
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States	3
A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine	3
Adolescent Aripiprazole-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome	3
Impact of Prior Psychiatric Diagnoses on the Incidence of Dissociative Symptoms Associated With Analgesic Ketamine Infusions in a Surgical Intensive Care Unit	3
A First Trimester Exposure to Ketamine and Esketamine for Depression	3
Journal of Clinical Psychopharmacology Updates	3
Journal of Clinical Psychopharmacology Updates	3
Panic Disorder Seeks More Specific Drugs for Treatment	3
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period	3
Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth	3
Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse	3
Venlafaxine-Associated Rhabdomyolysis	3
Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia	3
Toxidrome of an Easily Obtainable Nootropic	3
Global Insights Into Antipsychotic Research	3

The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms	3
Imipramine	3
Ketamine and Esketamine for Depression in Daily Practice	3
Reply to “All Patients With Catatonia Deserve Proper Diagnosis, Theragnosis, and Prognosis”	3
The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination	3
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder	3
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism	3
Ketamine as a Potential Neuromodulatory Treatment for Long COVID Neuropsychiatric and Neuropathic Symptoms	3
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium	3
Neutropenia Associated With Trazodone	3
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty	3
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia	3
Severe Alprazolam Withdrawal With Delirium and Psychosis	3
Premature Ejaculation After Discontinuation of Venlafaxine in a Case of Bipolar Depression	3
Assessing Adherence to Clozapine	3
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine	3
Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia	3
Semaglutide Misuse in Atypical Anorexia Nervosa—A Case Report	3
Evaluating the Quality of Randomized Controlled Trials	3
How Does Drug Company Marketing Affect Physician Prescribing?	3
Reply to “Xanomeline/Trospium Combination: Not Non-dopaminergic but a Novel Antidopaminergic Treatment for Schizophrenia”	3
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine	3
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient	3
New Onset of Seizures and Psychosis in a Patient Who Is Coprescribed Atomoxetine and Bupropion	3
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	3
A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings	3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants	3
Painful Ejaculation Associated With Atomoxetine and Bupropion	2
Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics	2
Clinician Reasons for Stopping Clozapine	2
Variability in Response to Antidepressants	2
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder	2
Adverse Reactions to Clozapine	2
Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression	2
Blepharospasm Arising From Escitalopram Use	2
Catatonia Associated With Valbenazine Treatment	2
Advancing the Development of New Medications to Treat Psychiatric Illness	2
Hypotension and Peripheral Edema With Moclobemide	2
A Call for the Study of Zuranolone as a Novel Treatment for Premenstrual Dysphoric Disorder	2
Serotonin Synthesis Amplification to Augment the Therapeutic Efficacy of Serotonin Reuptake Inhibitor Antidepressants	2
Beyond Clozapine	2
Modafinil Use in an Adolescent With Major Depressive Disorder	2
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination	2
Exploratory Case Series Assessing the Potential Interaction Between Lithium and Sodium-Glucose Cotransporter-2 Inhibitors	2
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder	2
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India	2
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-19	2
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia	2
The Efficacy of Methylphenidate Use in Children Diagnosed With Attention Deficit Hyperactivity Disorder With Emotional Impulsivity Symptoms	2
The Synergistic Effect of Bupropion-Dextromethorphan With Thyroid Supplementation in Treatment-Resistant Depression	2
Question	2
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data	2
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders	2
Semaglutide-Mediated Lithium Toxicity	2
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications	2
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I	2
Risk of Neutropenia Associated With Duloxetine	2
A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder	2
Levodopa Augmentation of Antipsychotics for Persistent Negative Symptoms in Schizophrenia	2
Question	2
The Rise and Fall of the Age of Psychopharmacology	2
Antimicrobial Exposure and Risk for Incident Major Depressive Disorder	2
Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals	2
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum	2
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder	2
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents	2
Amantadine as an Alternative to VMAT2 Inhibitors for Tardive Dyskinesia in Patients at Risk of Depression and Suicidality	2
Question	2
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress	2
Statistical Versus Clinical Significance	2
Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine	2
Current Clinical Psychopharmacology Integrated Practice	2
Fifty-Nine-Year-Old Woman With Concurrent Administration of Cobicistat and Dexamethasone Potentially Leading to Mania	2
Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine	2
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics	2
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder	2
Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine	2
α-PVP Associated Psychosis	2
Question	2
Fact Versus Fear	2
Obesity Associated With Symptomatic Remission in Clozapine-Treated Individuals With Treatment-Resistant Schizophrenia	2
Question	2
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”	2
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic	2
Effects of Adjunctive Brexpiprazole in Major Depressive Disorder Analyzed by Baseline Anxiety Level	2
Evaluating the Effectiveness of Cyproheptadine on Acute Neuroleptic-induced Akathisia	2
The Impact of Antidepressant Medications on Sleep in Children	2
Lemborexant Attenuates Methamphetamine Craving and Euphoria	2
Sleep-wake Disorders	2
Response of Gambling Disorder to Semaglutide	2
Antidepressant Poisoning Trends in Pediatric Intensive Care	2
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder	2
Citalopram-Associated Hyponatremia Presenting as Distal Extremity Numbness	2
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine	2
Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Re	2